Phase III randomized trial of CCRT versus neoadjuvant chemotherapy plus radiotherapy for NPC

被引：0
|
作者：
Lin, P. J. [1 ]
Liu, Y. C. [1 ]
Wang, W. Y. [2 ]
Lin, J. C. [1 ]
机构：
[1] Taichung Vet Gen Hosp, Dept Radiat Oncol, Taichung, Taiwan
[2] Hung Kuang Univ, Dept Nursing, Taichung, Taiwan
来源：
RADIOTHERAPY AND ONCOLOGY | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0638
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [31] NACT plus IMRT versus NACT plus IMRT plus CCRT in locoregionally advanced NPC patients: a retrospective study
    Chen, Xialin
    Zhu, Xiang
    Wang, Jianfang
    Liu, Jianjiang
    Ji, Rong
    ONCOTARGETS AND THERAPY, 2019, 12 : 1553 - 1562
  • [32] A phase III trial in progress comparing tislelizumab plus concurrent chemoradiotherapy (cCRT) with placebo plus cCRT in patients with localized esophageal squamous cell carcinoma (ESCC)
    Wang, Wei-Hu
    Li, Jiancheng
    Li, Tao
    Zhao, Kuaile
    Yu, Rong
    Wang, Wenqing
    Chen, Mingqiu
    Liang, Long
    Zou, Jiyan
    Wang, Yidi
    Shen, Wei
    Wu, Zhe
    Xiao, Zefen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [33] Randomized phase III trial of adjuvant sequential chemotherapy plus radiotherapy versus adjuvant radiotherapy alone for locally advanced bladder cancer after radical cystectomy: Urothelial carcinoma subgroup analysis.
    Zaghloul, Mohamed S.
    Christodouleas, John Paul
    Hwang, Wei-Ting
    Smith, Andrew
    Abdalla, Ahmed
    William, Hany
    Baumann, Brian Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [34] Phase Ib Trial of Neoadjuvant Low Dose Radiotherapy, Chemotherapy, and Durvalumab for Potentially Resectable Stage III NSCLC
    Li, J.
    Li, Q.
    Lu, S.
    Jiang, L.
    Li, L.
    Xie, S. -H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S158 - S159
  • [35] Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas
    Beauvillain, C
    Mahe, M
    Bourdin, S
    Peuvrel, P
    Bergerot, P
    Riviere, A
    Vignoud, J
    Deraucourt, D
    Wesoluch, M
    LARYNGOSCOPE, 1997, 107 (05): : 648 - 653
  • [36] Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfractionation in stage III and IV nasopharyngeal carcinoma - A phase II study
    El-Weshi, A
    Khafaga, Y
    Allam, A
    Mosseri, V
    Ibrahim, E
    El-Serafi, M
    El-Badawi, S
    ACTA ONCOLOGICA, 2001, 40 (05) : 574 - 581
  • [37] Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer
    Bajorin, DF
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) : 17S - 20S
  • [38] Neoadjuvant nivolumab (N) plus ipilimumab (I) vs chemotherapy (C) in the phase III CheckMate 816 trial
    Awad, M. M.
    Forde, P. M.
    Girard, N.
    Spicer, J. D.
    Wang, C.
    Lu, S.
    Mitsudomi, T.
    Felip, E.
    Broderick, S.
    Swanson, S. J.
    Brahmer, J. R.
    Kerr, K. M.
    Saylors, G.
    Chen, K-N.
    Cai, J. L.
    Mahmood, J.
    Neely, J.
    Balli, D.
    Hu, N.
    Pulla, M. Provencio
    ANNALS OF ONCOLOGY, 2023, 34 : S731 - S731
  • [39] Comparison of progression-free survival in gastric cancer patients receiving neoadjuvant chemotherapy alone versus chemotherapy plus concurrent chemoradiotherapy: a randomized, multi-center phase III clinical trial (in progress)
    Haddad, P.
    Ali-Moghaddam, K.
    Mahmoodzadeh, H.
    Lashkari, M.
    Kalaghchi, B.
    Sharifi-Aliabadi, L.
    ANNALS OF ONCOLOGY, 2016, 27 : 27 - 27
  • [40] RANDOMIZED STUDY COMPARING CHEMOTHERAPY PLUS RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN FIGO STAGE-IIB-III CERVICAL-CARCINOMA
    CHIA, S
    BRUZZONE, M
    MERLINI, L
    PRUZZI, P
    ROSSO, R
    FRANZONE, P
    ORSATTI, M
    VITALE, V
    FOGLIA, G
    ODICINO, F
    RAGNI, N
    RUGIATI, S
    CONTE, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (04): : 294 - 297
12345